Browsing Tag
Dr. Reddy’s Laboratories
66 posts
Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V Covid-19 vaccine
Dr. Reddy’s Laboratories has recently received approval from the Drugs Control General of India (DCGI) to proceed with…
January 16, 2021
Dr. Reddy’s reports success in Sputnik V phase 2 trial, paving the way for phase 3 in India
Dr. Reddy’s Laboratories has announced a major milestone in the development of Sputnik V, the Russian Covid-19 vaccine,…
January 14, 2021
Dr. Reddy’s launches Sapropterin Dihydrochloride Tablets generic version in US
Indian pharma company Dr. Reddy’s Laboratories has launched a generic version of phenylalanine hydroxylase activator Sapropterin Dihydrochloride Tablets,…
October 4, 2020
Dr. Reddy’s, RDIF to bring Sputnik V coronavirus vaccine to India
Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories have agreed to cooperate on clinical trials and distribution…
September 17, 2020
Dr Reddy’s Laboratories to acquire generic injectable products in the US
Dr Reddy’s Laboratories has agreed to acquire a portfolio of 42 approved, non-marketed abbreviated new drug applications (ANDAs)…
April 19, 2019
Marc Kikuchi appointed CEO of Dr. Reddy’s North America Generics unit
Dr. Reddy’s Laboratories has announced the appointment of Marc Kikuchi as the CEO of its North America Generics…
February 3, 2019